These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 18215109)
41. Systematic identification of drugs that cause birth defects--a new opportunity. Mitchell AA N Engl J Med; 2003 Dec; 349(26):2556-9. PubMed ID: 14695418 [No Abstract] [Full Text] [Related]
42. Research and development costs for drugs. Riggs TL Lancet; 2004 Jan; 363(9404):184. PubMed ID: 14738789 [No Abstract] [Full Text] [Related]
43. [From molecule to medicine--drug development]. Bruhn C Dtsch Med Wochenschr; 2010 Feb; 135(6):p5. PubMed ID: 20151355 [No Abstract] [Full Text] [Related]
44. Drugs in pregnancy. Forsell P Aust Fam Physician; 1982 Dec; 11(12):975-6. PubMed ID: 7159290 [No Abstract] [Full Text] [Related]
46. Opinion: development of new drugs is still a risky business. Franks B N J Med; 2002; 99(1-2):60, 59. PubMed ID: 15326736 [No Abstract] [Full Text] [Related]
47. Access to investigational drugs for patients with amyotrophic lateral sclerosis in the USA. Lynch HF; Morris S; Andrews JA Lancet Neurol; 2022 Jul; 21(7):593-594. PubMed ID: 35716691 [No Abstract] [Full Text] [Related]
48. Doubters ask if IOM report will foster more sharing of clinical trial data. Rice S Mod Healthc; 2015 Jan; 45(3):10. PubMed ID: 25671895 [No Abstract] [Full Text] [Related]
49. [Does the public sector have an independent research role in the development of drugs?]. Poulsen HE; Grønlykke TB Ugeskr Laeger; 2003 Apr; 165(16):1674-6. PubMed ID: 12756828 [TBL] [Abstract][Full Text] [Related]
50. Biotech R&D goes further afield. Lawrence S Nat Biotechnol; 2006 Sep; 24(9):1052. PubMed ID: 16964201 [No Abstract] [Full Text] [Related]
51. The biotech drug market. Lawrence S Nat Biotechnol; 2004 Dec; 22(12):1496. PubMed ID: 15583645 [No Abstract] [Full Text] [Related]
52. Collection and analysis of drug safety data in pregnancy. Moretti M Can J Clin Pharmacol; 2007; 14(1):e34-6. PubMed ID: 17213508 [No Abstract] [Full Text] [Related]
53. Financial ties to industry cloud major depression study; at issue: whether it's safe for pregnant women to stay on medication; JAMA asks author to explain. Armstrong D Wall St J (East Ed); 2006 Jul; ():A1, A9. PubMed ID: 16909497 [No Abstract] [Full Text] [Related]
54. Impact of celebrity pitch in direct-to-consumer advertising of prescription drugs. Bhutada NS; Menon AM; Deshpande AD; Perri M Health Mark Q; 2012; 29(1):35-48. PubMed ID: 22416924 [TBL] [Abstract][Full Text] [Related]
55. Merck's recall of rofecoxib--a strategic perspective. Oberholzer-Gee F; Inamdar SN N Engl J Med; 2004 Nov; 351(21):2147-9. PubMed ID: 15548771 [No Abstract] [Full Text] [Related]
56. Patent laws: could changes enhance drug development? Mattes JA Arch Gen Psychiatry; 1997 Oct; 54(10):970. PubMed ID: 9337779 [No Abstract] [Full Text] [Related]
57. The drug war. Meyer CR Minn Med; 2000 Jan; 83(1):2, 57. PubMed ID: 10680422 [No Abstract] [Full Text] [Related]
58. Teratogenic drugs and their drug interactions with hormonal contraceptives. Ahn MR; Li L; Shon J; Bashaw ED; Kim MJ Clin Pharmacol Ther; 2016 Sep; 100(3):217-9. PubMed ID: 27090193 [TBL] [Abstract][Full Text] [Related]